Administration

Below you will find details on administering Prevnar 13® to your patients.2
Administration considerations for Prevnar 13®2
  • Approved as a single dose
  • Packaged as a pre-filled syringe
  • The tip cap and rubber plunger of the pre-filled syringe are not made with natural rubber latex
  • Shake vigorously prior to use to obtain a homogenous, white suspension in the vaccine container
  • Do not use the vaccine if it cannot be suspended or if particulate matter or discoloration is found
  • For intramuscular use only
  • The preferred site for injection in adults is the deltoid muscle of the upper arm. Do not inject in the gluteal area or areas where there may be a major nerve trunk and/or blood vessel
  • After being shipped, Prevnar 13® may arrive at temperatures between 2°C and 25°C (36°F and 77°F)
  • Store refrigerated at 2°C to 8°C (36°F to 46°F)
  • Prevnar 13® should not be allowed to freeze. If vaccine has frozen, it must be discarded
  • Prevnar 13® is stable at temperatures up to 25°C (77°F) for 4 days. These data are not recommendations for shipping or storage, but may guide decisions for use in case of temporary temperature excursions.2
ACIP=Advisory Committee on Immunization Practices; CDC=Centers for Disease Control and Prevention.